Loading...

Table of Content

    18 December 2026, Volume 30 Issue 35 Previous Issue   
    For Selected: Toggle Thumbnails
    Asiaticoside promotes osteogenic differentiation in osteoporotic rats
    Xu Hongtao, Wang Jianping, Xu Yuehong, Li Qin, Qi Qihua, Xia Qipeng
    2026, 30 (35):  9113-9119.  doi: 10.12307/2026.430
    Abstract ( 32 )   PDF (2022KB) ( 10 )   Save
    BACKGROUND: Studies have indicated that asiaticoside possesses multiple pharmacological functions, including anti-inflammatory and antioxidant properties, and exerts a positive effect on osteogenic differentiation. It may serve as a potential therapeutic agent for osteoporosis.
    OBJECTIVE: To investigate the effects of asiaticoside on osteogenic differentiation in osteoporotic rats. 
    METHODS: (1) Animal models of osteoporosis were established by removing both ovaries in 52 female Sprague-Dawley rats. Simultaneously, equivalent volumes of adipose tissue near the ovaries were removed bilaterally from 10 female Sprague-Dawley rats as the sham operation group. At 8 weeks after modeling, 50 model rats were randomly divided into five intervention groups: model group (n=10) was administered saline via oral gavage; low-dose asiaticoside group (n=10) was administered 16 mg/(kg·d) asiaticoside via oral gavage; high-dose asiaticoside group (n=10) was administered 32 mg/(kg·d) asiaticoside via oral gavage; positive control group (n=10) was subjected to oral administration of sodium alendronate tablets at 7.35 mg/(kg·d); and high-dose asiaticoside + activator group (n=10) received concurrent oral administration of 32 mg/(kg·d) asiaticoside + 300 mg/(kg·d) NLRP3 activator, once daily for 6 consecutive weeks. After drug administration, tissue samples were collected. Serum levels of interleukin-1β and interleukin-18 were measured. Micro-CT scans were performed on the distal femur. Hematoxylin-eosin staining was used to observe histological changes in the femur. Western blot assay was conducted to detect the expression of tripartite motif-containing protein 24 (TRIM24), NLRP3, and cleaved caspase-1 in the femur. (2) Rat bone marrow mesenchymal stem cells at the logarithmic growth stage were divided into four groups: blank group with no treatment, asiaticoside group treated with 20 µmol/L asiaticoside, asiaticoside+empty carrier group treated with 20 µmol/L asiaticoside for 48 hours after transfection with the empty vector plasmid for 48 hours, and asiaticoside+NLRP3 overexpression group treated with 20 µmol/L asiaticoside for 48 hours after transfection with the NLRP3 overexpression plasmid for 48 hours. After 7 days of inducing osteogenic differentiation, the activity of alkaline phosphatase and mRNA expression of osteopontin, osteocalcin, TRIM24, and NLRP3 were detected. 
    RESULTS AND CONCLUSION: (1) Animal experiment: The levels of interleukin-1β and interleukin-18 in the low-dose asiaticoside group, high-dose asiaticoside group, and positive control group were all lower than those in the model group (P < 0.05). The levels of interleukin-1β and interleukin-18 in the high-dose asiaticoside + activator group were higher than those in the high-dose asiaticoside group (P < 0.05). Micro-CT scans and hematoxylin-eosin staining revealed that compared with the model group, the microstructure and histomorphology of the femur were significantly improved in the low-dose and high-dose asiaticoside groups as well as in the positive control group. However, NLRP3 activator partially inhibited the effects of high-dose asiaticoside. Compared with the model group, the low-dose asiaticoside group, high-dose asiaticoside group, and positive control group showed increased expression of TRIM24 protein (P < 0.05) and decreased expression of NLRP3 and cleaved caspase-1 protein (P < 0.05). Compared with the high-dose asiaticoside group, the high-dose asiaticoside + activator group showed lower protein expression of TRIM24 (P < 0.05), but higher protein expression of NLRP3 and cleaved caspase-1 (P < 0.05). (2) Cell experiment: The alkaline phosphatase activity in the asiaticoside group was higher than that in the blank group and the asiaticoside + NLRP3 overexpression group (P < 0.05). RT-PCR revealed that the asiaticoside group showed higher mRNA expression levels of osteopontin, osteocalcin, and TRIM24 but lower NLRP3 mRNA expression compared with the control group and the asiaticoside + NLRP3 overexpression group (all P < 0.05). To conclude, asiaticoside may promote osteogenic differentiation of bone marrow mesenchymal stem cells and delay osteoporosis progression in osteoporotic rats by upregulating TRIM24 and inhibiting NLRP3 expression.

    Figures and Tables | References | Related Articles | Metrics
    Nimbolide relieves osteoporosis by regulating osteoclast differentiation and apoptosis
    Li Wenhao, Zhang Wei, Li Wenming, Xia Wenyu, Wu Zebin, Geng Dechun
    2026, 30 (35):  9120-9127.  doi: 10.12307/2026.260
    Abstract ( 27 )   PDF (6903KB) ( 14 )   Save
    BACKGROUND: Nimbolide, a triterpenoid bioactive compound, exhibits multiple biological activities including anti-inflammatory, antioxidant, antitumor, and antibacterial effects. However, its potential to alleviate osteoporosis by regulating osteoclast differentiation and apoptosis remains unreported.
    OBJECTIVE: To investigate the effects of nimbolide on osteoclast differentiation, osteoclast apoptosis, and osteoporosis.
    METHODS: (1) Cell experiments: Mouse bone marrow-derived macrophages were divided into four groups: the cells were cultured in α-MEM complete medium containing macrophage colony-stimulating factor in the control group; the cells were cultured in α-MEM complete medium containing macrophage colony-stimulating factor and receptor activator of nuclear factor-κB ligand in the osteoclast induction group; the cells were cultured in osteoclast-inducing differentiation medium supplemented with 100 nmol/L or 200 nmol/L nimbolide, respectively in the low- and high-dose nimbolide groups. The effects of nimbolide on osteoclast differentiation and apoptosis were assessed using tartrate-resistant acid phosphatase staining, Annexin V-FITC/PI staining, and RT-qPCR. (2) In vivo experiments: Twenty-four 8-week-old female C57BL/6J mice were randomly divided into four groups: The mice in the sham group underwent only removal of perovarian fat; the mice in the model group underwent bilateral ovariectomy. The low-dose and high-dose nimbolide groups received intraperitoneal injections of 5 mg/kg and 10 mg/kg nimbolide solutions, respectively, every 2 days after modeling. Serum and femoral samples were collected after 8 weeks of modeling for relevant analyses.
    RESULTS AND CONCLUSION: (1) Cell experiments: RT-qPCR and tartrate-resistant acid phosphatase staining revealed that nimbolide inhibited the expression of osteoclast differentiation-related genes and suppressed osteoclast differentiation in vitro. RT-qPCR and Annexin V-FITC/PI staining demonstrated that nimbolide suppressed the expression of apoptosis-related genes and induced apoptosis in mature osteoclasts. RT-qPCR results demonstrated that nimbolide promotes osteoclast apoptosis through the Fas/Fasl signaling pathway, with its regulatory effects on osteoclast differentiation and apoptosis exhibiting concentration-dependent properties. (2) Animal experiments: Micro-CT and hematoxylin-eosin staining results demonstrated that nimbolide reduced bone loss in estrogen-deficient osteoporotic mice, with a more pronounced effect at 10 mg/kg; nimbolide had no significant impact on serum estradiol levels in ovariectomized mice. In vitro experiments confirm that nimbolide not only inhibits osteoclast differentiation but also promotes apoptosis in mature osteoclasts. In vivo experiments confirm that nimbolide can mitigate excessive bone loss in estrogen-deficient osteoporosis in mice.

    Figures and Tables | References | Related Articles | Metrics
    Bushen Jianpi Huoxue Formula inhibits bone loss and improves trabecular biomechanical parameters in ovariectomized rats
    Lin Shi, Yang Binbin, Tang Zijia, Dongzhi Zhuoma, Wu Jianjun, Chen Tongying, Wan Lei, Huang Hongxing, Huang Hong
    2026, 30 (35):  9128-9134.  doi: 10.12307/2026.464
    Abstract ( 37 )   PDF (34850KB) ( 6 )   Save
    BACKGROUND: Previous studies have confirmed that the Bushen Jianpi Huoxue Formula can increase bone mineral density in osteoporotic rats.
    OBJECTIVE: To investigate the effects of the Bushen Jianpi Huoxue Formula on bone loss and trabecular biomechanical parameters in ovariectomized rats.
    METHODS: Fifty female Sprague-Dawley rats were randomly divided into five groups: a normal group (n=10) without any intervention, a sham-operated group (n=10) undergoing resection of adipose tissue near the ovaries, and an ovariectomized group (n=10), a Bushen Jianpi Huoxue Formula group (n=10), and an alendronate group (n=10) undergoing bilateral ovariectomy to establish an osteoporosis model. Twelve weeks after modeling, the Bushen Jianpi Huoxue Formula group and the alendronate group were orally administered the Bushen Jianpi Huoxue Formula and alendronate, respectively, while the other three groups were orally administered normal saline, once daily for 12 consecutive weeks. After final treatment, lumbar spine bone mineral density was measured, micro-CT was used to analyze bone microstructure parameters of the distal femur and proximal tibia, hematoxylin-eosin staining was used to observe the histological morphology of the proximal tibia, and finite element analysis was used to analyze strain and stress in the distal femur.
    RESULTS AND CONCLUSION: (1) Lumbar spine bone mineral density in the ovariectomized group was lower than that in the normal and sham-operated groups (P < 0.05), while lumbar spine bone mineral density in the Bushen Jianpi Huoxue Formula group and the alendronate group was higher than that in the ovariectomized group (P < 0.05). (2) Micro-CT analysis showed that compared with the normal and sham-operated groups, the ovariectomized group exhibited significantly decreased bone volume fraction, bone surface density, and trabecular number (P < 0.05), as well as significantly increased trabecular separation and structure model index (P < 0.05) in the proximal tibia (or distal femur). Compared with the ovariectomized group, the Bushen Jianpi Huoxue formula and alendronate groups showed significantly increased bone volume fraction, bone surface density, and trabecular number in the distal femur (P < 0.05), significantly decreased trabecular separation and structure model index in the distal femur (P < 0.05), and significantly increased bone volume fraction, bone surface density, and trabecular number in the proximal tibia (P < 0.05). (3) Hematoxylin-eosin staining results showed that the degree of fatty infiltration in the bone marrow cavity was significantly higher in the ovariectomized group than in the normal and sham-operated groups. The Bushen Jianpi Huoxue Formula and alendronate groups showed marked improvement in bone marrow adiposity. (4) Finite element analysis showed that under the same load, trabecular stress and strain in the ovariectomized group were significantly higher than those in the normal and sham-operated groups (P < 0.05). The Bushen Jianpi Huoxue formula and alendronate groups exhibited significantly improved trabecular stress and strain compared with the ovariectomized group (P < 0.05). In conclusion, the Bushen Jianpi Huoxue Formula can prevent bone loss, improve bone microstructure, and enhance trabecular biomechanical properties in ovariectomized rats, indicating its potential efficacy in preventing osteoporotic fractures.
    Figures and Tables | References | Related Articles | Metrics
    Mechanism of spontaneous resorption in lumbar disc herniation and new strategies for precision treatment
    Aikeremujiang·Muheremu, Aikebaierjiang·Aisaiti, Alimujiang·Abudurousuli, Kutiluke·Shoukeer, Sala Yiding·Aierxiding, Abuduwupuer·Tailaiti, Abudunaibi·Aili, Jia Zhiwei
    2026, 30 (35):  9135-9142.  doi: 10.12307/2026.431
    Abstract ( 53 )   PDF (2152KB) ( 16 )   Save
    BACKGROUND:  Lumbar disc herniation is a prevalent spinal degenerative disorder in clinical practice. Traditional treatment predominantly relies on surgical intervention; however, the phenomenon of spontaneous resorption in lumbar disc herniation offers a novel non-surgical approach.
    OBJECTIVE: To investigate the efficacy of a comprehensive non-surgical treatment regimen in promoting the spontaneous resorption of a severely herniated L5/S1 
    disc through a two-year follow-up observation of a single patient, as well as to elucidate the mechanisms underlying disc spontaneous resorption and identify key indicators predictive of resorption potential.
    METHODS: A single patient with severe L5/S1 disc herniation was selected and treated with a comprehensive non-surgical approach comprising non-steroidal anti-inflammatory drugs, physical therapy, and exercise rehabilitation. The patient was followed up for 2 years, during which changes in pain symptoms were closely monitored, and serial MRI examinations were conducted to dynamically record the evolution of the herniated material. Extensive literature review was also performed to deeply analyze the potential mechanisms of disc spontaneous resorption.
    RESULTS AND CONCLUSION: After 2 years of comprehensive non-surgical treatment, the patient's pain symptoms significantly improved, with a marked reduction in the Visual Analogue Scale score. Magnetic resonance imaging clearly showed gradual resorption of the herniated material, confirming the therapeutic efficacy in promoting spontaneous resorption. The spontaneous resorption of the disc was found to be mediated by a coordinated biological process involving inflammatory response activation and neovascularization. Key indicators predictive of resorption potential were identified, including the characteristics of the herniated material, magnetic resonance imaging edge enhancement signs, and the status of the posterior longitudinal ligament. Furthermore, future research could leverage single-cell sequencing, multimodal imaging, and deep learning technologies to elucidate molecular mechanisms, realize early prediction, and assist in precise clinical treatment. In summary, this comprehensive non-surgical treatment regimen provides a reliable foundation for the management of lumbar disc herniation. The elucidation of multi-mechanism synergy clarifies the principles of resorption, while key predictive indicators facilitate the development of personalized treatment plans. The application of cutting-edge technologies points the way toward transforming the treatment of lumbar disc herniation into precise biotherapy and enhancing clinical outcomes.

    References | Related Articles | Metrics
    Effects of physiological osmotic pressure on chondrocyte differentiation and extracellular matrix metabolism
    Chen Yida, Cheng Xinyi, Zhao Huan, Zhou Xichao, Gu Qiaoli, Lin Xiao, Shi Qin
    2026, 30 (35):  9143-9150.  doi: 10.12307/2026.284
    Abstract ( 38 )   PDF (2747KB) ( 20 )   Save
    BACKGROUND: The vicious cycle of osteoarthritis initiation and progression is driven by the combined effects of mechanical microenvironment disruption and collapse of osmotic pressure homeostasis. Sustained abnormal osmotic pressure disrupts chondrocyte homeostasis and markedly impairs the ability of bone marrow mesenchymal stem cells to differentiate into chondrocytes. Consequently, this compromises the regenerative capacity of cartilage and accelerates the degeneration of articular cartilage.
    OBJECTIVE: To develop a pathological osmotic pressure model for use in osmotic intervention experiments, in order to investigate the effects of osmotic pressure on chondrogenic differentiation of bone marrow mesenchymal stem cells and chondrocyte matrix metabolism, and to explore the role of imbalanced osmotic pressure within the joint cavity in the pathogenesis of osteoarthritis.
    METHODS: Bone marrow mesenchymal stem cells were isolated from 6- to 8-week-old rats and cultured to the third passage. Third-passage rat chondrocytes were revived and performed expansion culture. Physiological or pathological osmotic pressure regulating solutions were prepared by adding NaCl to the culture medium, and their biocompatibility was assessed via cell counting kit-8 assays. Bone marrow mesenchymal stem cells were treated with different osmotic pressure regulating solutions in chondrogenic induction medium for 7 or 14 days. Safranin O staining was used to identify the secretion of glycosaminoglycan (a cartilage marker). qRT-PCR was performed to detect expression of genes related to cartilage synthesis. The effects of physiological or pathological osmotic pressure regulating solution on chondrocyte anabolism and catabolism were further evaluated after interleukin-1β inflammation induction. Furthermore, RNA-seq was employed to identify differentially expressed genes between the physiological and pathological osmotic pressure groups and an enrichment analysis was performed.
    RESULTS AND CONCLUSION: (1) Third-passage bone marrow mesenchymal stem cells were successfully isolated and cultured, and third-passage chondrocytes were successfully revived and expanded. (2) Cell counting kit-8 assay demonstrated that these physiological and pathological osmotic pressure regulating solutions exhibited good biocompatibility. (3) Safranin O staining indicated that the chondrogenic capacity of the physiological osmotic pressure group was significantly enhanced compared to the pathological osmotic pressure group on both day 7 and day 14. (4) qRT-PCR further confirmed that compared with the interleukin 1β group and the pathological osmotic pressure group, the physiological osmotic pressure group could significantly upregulate the expression of cartilage synthesis-related genes aggrecan and collagen type II α1 chain, while downregulating the catabolism-related genes matrix metalloproteinase 13 and matrix metalloproteinase 3. (5) RNA sequencing results revealed that under physiological osmotic conditions, the expression of multiple molecules and signaling pathways associated with osteoarthritis pathogenesis was markedly suppressed. 
    Figures and Tables | References | Related Articles | Metrics
    Effects of cobimetinib versus combination of dasatinib and quercetin on stress-induced chondrocyte senescence
    Zhao Minjun, , Wu Xubo, , Yin Jianli, , Ge Yangshuo, Ding Jiaying, Huang Chunmeng, Meng Tingting, Wang Xuezong, Liu Zhenfeng, Ding Daofang
    2026, 30 (35):  9151-9158.  doi: 10.12307/2026.432
    Abstract ( 41 )   PDF (5663KB) ( 13 )   Save
    BACKGROUND:  Osteoarthritis is closely related to aging and characterized by degeneration of articular cartilage, subchondral bone sclerosis, and low-grade inflammatory responses. Aging and injury are significant triggers for inflammatory factors that mediate joint pathological changes. Cobimetinib, a MEK1 inhibitor, has an unclear effect on the inflammatory senescence of chondrocytes.
    OBJECTIVE: To compare the effects of cobimetinib and the classical senolytic drug combination of dasatinib and quercetin (D+Q) in suppressing inflammation-induced chondrocyte senescence, and to explore their potential therapeutic value in osteoarthritis.
    METHODS: Primary chondrocytes were isolated and cultured. Cell viability was assessed by cell counting kit-8 assay. Cells were divided into control, model, D+Q, and cobimetinib groups. Except for the control group, inflammatory senescence chondrocyte models were induced by interleukin-1β in the other three groups. The cobimetinib and D+Q groups were treated with cobimetinib and D+Q, respectively. Senescent phenotypes were evaluated using SA-β-Gal staining. The activation status of the MEK-ERK1/2 pathway, expression levels of senescence markers (P16, P21, P53) and senescence-associated secretory phenotype factors (such as inducible nitric oxide synthase, cyclooxygenase-2, chemokine 3, interleukin-6) were analyzed by real-time quantitative PCR, western blot, and immunofluorescence. Additionally, changes in molecules related to extracellular matrix synthesis and degradation (COL2A1, matrix metalloproteinase-13, and matrix metalloproteinase-3) were assessed.
    RESULTS AND CONCLUSION: Both cobimetinib and D+Q could effectively inhibit the activation of the MEK-ERK1/2 pathway, ameliorate the senescent phenotypes of chondrocytes, as evidenced by downregulation of P16, P21, and P53, attenuation of senescence-associated secretory phenotype factor levels, restoration of COL2A1 expression, and suppression of matrix metalloproteinase-13 and matrix metalloproteinase-3. Overall, cobimetinib effectively alleviates interleukin-1β-induced inflammatory senescence in chondrocytes by inhibiting the MEK-ERK1/2 pathway. Compared with D+Q, it exhibits comparable anti-senescent effects while demonstrating greater potential in promoting matrix synthesis and inhibiting degradation.

    Figures and Tables | References | Related Articles | Metrics
    An association between preoperative dental anxiety and the time of mandibular third molar extraction
    Li Lei, Bai Xiaolong, Li Jiaye, Wang Weili
    2026, 30 (35):  9159-9164.  doi: 10.12307/2026.415
    Abstract ( 38 )   PDF (1367KB) ( 5 )   Save
    BACKGROUND: Patients undergoing mandibular third molar extraction show significantly higher dental anxiety levels than those receiving other dental procedures. Preoperative anxiety not only prolongs operation time but also worsens postoperative complications.
    OBJECTIVE: To investigate the relationship between preoperative dental anxiety and the time of mandibular third molar extraction. 
    METHODS: A cross-sectional observational study was designed for the patient’s extraction of mandibular third molar in the outpatient clinic of Department of Stomatology of Aerospace Center Hospital. The Modified Dental Anxiety Scale for Third Molar Surgery (MDAS-TMS) was used to evaluate the preoperative anxiety status. Demographic characteristics, surgical and radiographic features of the patients were recorded. The main outcome indicator was the duration of surgery. Multivariable linear regression models were developed to analyze their influences, and a restricted cubic spline function was used to evaluate their potential nonlinear associations.
    RESULTS AND CONCLUSION: A total of 216 patients (71 men and 145 women) were included in the study. The mean DAS-TMS score was 10.4, 32.4% were mildly anxious, and 8.8% were highly anxious. For each 1-unit increase in the DAS-TMS after multivariate adjustment, operative time increased by 1.1 minutes (β=1.10, P < 0.001, 95% confidence interval: 0.76-1.49). Evidence of a nonlinear association was observed (P=0.013 for nonlinearity). These findings indicate that preoperative dental anxiety has a significant effect on the time of mandibular third molar extraction procedure.

    Figures and Tables | References | Related Articles | Metrics
    Mechanisms by which voluntary wheel running improves endothelial progenitor cell function in diabetic rats
    Pan Dong, Yang Jialing, Tian Wei, Wang Dongji, Zhu Zheng, Ma Wenchao, Liu Na, Fu Changxi
    2026, 30 (35):  9165-9173.  doi: 10.12307/2026.422
    Abstract ( 32 )   PDF (4501KB) ( 7 )   Save
    BACKGROUND: Exercise therapy is a non-drug management strategy for diabetic patients and can significantly improve endothelial function. However, its effect on endothelial progenitor cells and its specific biological mechanism are still unclear. 
    OBJECTIVE: To explore the effects of voluntary wheel running on the function of endothelial progenitor cells in type 2 diabetic rats and reveal the possible mechanisms of action.
    METHODS: (1) Animal experiment: Sixty Wistar rats were randomly divided into four groups. The control group (n=15) underwent neither modeling nor any exercise intervention. In the model group (n=15), a rat model of type 2 diabetes was established using a high-fat diet combined with streptozotocin induction, with no exercise intervention after modeling. In the model exercise group (n=15), model rats underwent voluntary wheel running for 5 days per week over 8 weeks. In the model exercise + gene silencing group (n=15), model rats received tail vein injection of insulin-like growth factor 1 receptor-specific small interfering RNA adenovirus recombinant virus and voluntary wheel running, 5 days per week for 8 weeks, commenced at 4 hours after injection. Following the exercise intervention, fasting blood glucose, serum insulin-like growth factor-1 and insulin levels, and insulin resistance indices were measured. Endothelial vasodilatory function of the thoracic aorta was assessed using an in vitro vascular loop assay. (2) Cell experiment: After the exercise intervention, bone marrow endothelial progenitor cells were isolated and cultured in vitro. The proliferation, migration and tube formation abilities of endothelial progenitor cells were measured by MTT method, cell scratch test and Matrigel tube formation test, respectively. Real-time fluorescent quantitative PCR was used to detect intracellular insulin-like growth factor 1 receptor mRNA expression levels. The protein expression of insulin-like growth factor 1, insulin-like growth factor 1 receptor, phosphorylated phosphatidylinositol-3 kinase and phosphorylated protein kinase B proteins in endothelial progenitor cells was detected by western blot assay. 
    RESULTS AND CONCLUSION: (1) Animal experiment: Compared with the control group, rats in the model group exhibited elevated fasting blood glucose, insulin levels, and insulin resistance index (P < 0.05), while decreased insulin-like growth factor 1 levels (P < 0.05). Compared with the model exercise group, fasting blood glucose level, insulin level, and insulin resistance index were elevated in the model group and the model exercise + gene silencing group (P < 0.05), while insulin growth factor-1 levels were reduced in the model group (P < 0.05). The model group, model exercise group, and model exercise + gene silencing group exhibited weaker vascular endothelial relaxation function than the control group (P < 0.05). The model exercise group demonstrated stronger endothelial vasodilatory function than the model group and the model exercise + gene silencing group (P < 0.05). (2) Cell experiment: The model group exhibited lower proliferation, migration, and tubule formation capabilities of bone marrow endothelial progenitor cells, as well as lower insulin-like growth factor 1 receptor mRNA expression compared with the control group. The model exercise group showed higher proliferation, migration, and tubule formation capabilities of bone marrow endothelial progenitor cells, as well as higher insulin-like growth factor 1 receptor mRNA expression than both the model group and the model exercise + gene silencing group (P < 0.05). The model group exhibited lower expression of insulin-like growth factor 1, insulin-like growth factor 1 receptor, phosphorylated phosphoinositide 3-kinase, and phosphorylated protein kinase B compared with the control group (P < 0.05). In the model exercise group, the expression of insulin-like growth factor 1 receptor, phosphorylated phosphoinositide 3-kinase, and phosphorylated protein kinase B was higher than that in the model group and the model exercise + gene silencing group (P < 0.05), while insulin-like growth factor 1 protein expression was higher than that in the model group (P < 0.05). To conclude, voluntary wheel running improves the function of endothelial progenitor cells in rats with type 2 diabetes, and its mechanism is related to the activation of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway mediated by insulin-like growth factor 1 receptor. 
    Figures and Tables | References | Related Articles | Metrics
    Construction and functional verification of vascular endothelial growth factor receptor 2 gene knockdown rats
    Qian Jiaming, Li Yumei, Wang Xiaole, Fang Ting, Liu Fushui
    2026, 30 (35):  9174-9181.  doi: 10.12307/2026.454
    Abstract ( 36 )   PDF (2789KB) ( 8 )   Save
    BACKGROUND: Vascular endothelial growth factor receptor 2 is mainly expressed in vascular endothelial cells and plays a crucial role in angiogenesis, tissue repair, and the occurrence and development of diseases. Adeno-associated virus, due to its unique advantages, has been widely applied in mechanism research, disease modeling, and gene therapy fields.
    OBJECTIVE: To construct an adeno-associated viral vector for vascular endothelial growth factor receptor 2 gene knockdown in rat muscle tissue, determine the knockdown efficiency of vascular endothelial growth factor receptor 2 gene-knockdown adeno-associated virus in the rat sternocleidomastoid muscle and assess its effects on muscle and blood vessels.
    METHODS: The vector was constructed, and packaged into adeno-associated virus. Following target screening experiments in Sprague-Dawley rats, immunofluorescence assays were conducted to assess viral infection efficiency and vascular endothelial growth factor receptor 2 protein expression. Quantitative real-time PCR was used to measure vascular endothelial growth factor receptor 2 mRNA expression. Ultimately, the optimal shRNA sequences were determined to be Y29478 and the control sequence Y9957. Twelve Sprague-Dawley rats were randomly divided into an adeno-associated virus group and a control adeno-associated virus group for functional validation. Adeno-associated virus was injected into the rat splenius capitis muscle. Twenty weeks later, fluorescent quantitative PCR and western blot were used to detect vascular endothelial growth factor receptor 2 mRNA and protein expression in the neck muscles. Hematoxylin-eosin staining was used to measure the cross-sectional area of muscle fibers in the neck muscles, and CD31 immunohistochemistry was used to detect the number of microvessels in the neck muscles.
    RESULTS AND CONCLUSION: (1) The shRNA sequence and adeno-associated virus dose that could knock down the expression of vascular endothelial growth factor receptor 2 were successfully screened, and the vascular endothelial growth factor receptor 2 knockdown efficiency of rat muscle tissue after in-situ injection of adeno-associated virus with vascular endothelial growth factor receptor 2 reached 60%. (2) Compared with the control adeno-associated virus group, the mRNA and protein expression of vascular endothelial growth factor receptor 2, the muscle fiber area and the number of microvessels in the adeno-associated virus group decreased. (3) A rat model of vascular endothelial growth factor receptor 2 knockdown was successfully established. Knockdown of vascular endothelial growth factor receptor 2 in muscle tissue resulted in reduced muscle fiber cross-sectional area and decreased microvessel number. 
    Figures and Tables | References | Related Articles | Metrics
    Zizhu ointment enhances wound healing in diabetic ulcer mice via angiogenesis regulation
    Li Wenhui, Shi Chenyan, Yang Yiyan, Liu Guobin
    2026, 30 (35):  9182-9188.  doi: 10.12307/2026.434
    Abstract ( 39 )   PDF (2535KB) ( 8 )   Save
    BACKGROUND: Angiogenesis is one of the critical issues in chronic ulcer healing. Previous studies have indicated that Zizhu ointment can increase the expression of vascular endothelial growth factor in wounds, promote wound healing, and stimulate angiogenesis in high-glucose and high-lipid cell models.
    OBJECTIVE: To investigate the effects of Zizhu ointment on angiogenesis in diabetic ulcer model mice and elucidate its underlying mechanisms in promoting wound healing. 
    METHODS: Twenty-four mice were randomly divided into four groups: normal control, model control, saline-treated, and Zizhu ointment groups. The diabetic mouse model was established in the latter three groups through a high-fat diet combined with streptozotocin injections. After blood glucose stabilization, full-thickness dorsal skin was removed to simulate diabetic ulcers, with regular monitoring of body mass and blood glucose levels. In the Zizhu ointment group, wound dressings were changed daily. Wound conditions were documented photographically on days 3, 7, 11, and 14 post-injury, followed by skin sample collection on day 14. Histological analyses were performed using hematoxylin-eosin and Masson’s staining to evaluate wound healing. Angiogenesis was assessed by immunofluorescence staining for vascular endothelial growth factor A and CD34. Quantitative real-time PCR and western blot assay were used to analyze mRNA and protein expression of angiogenesis-related factors, including vascular endothelial growth factor A, angiopoietin-2, sprouty-related EVH1 domain-containing protein 1, and phosphoinositide 3-kinase regulatory subunit 2. 
    RESULTS AND CONCLUSION: (1) The diabetic ulcer mouse model was established successfully. Wound healing was significantly delayed in the model group. In contrast, the Zizhu ointment treatment group showed markedly accelerated healing compared with the model group at days 3, 7, 11, and 14 (P < 0.01), with particularly higher healing rates than those in the saline-treated group at days 7, 11, and 14 (P < 0.01). (2) Histopathological examination through hematoxylin-eosin and Masson’s staining revealed that compared with the control group, the model group exhibited enhanced inflammatory infiltration, reduced dermal appendages, and diminished neovascularization, while the Zizhu ointment group demonstrated improved tissue regeneration characterized by increased appendage formation and enhanced vascular cluster development. (3) Immunofluorescence staining for CD34 and vascular endothelial growth factor A revealed a reduction in positive cells within ulcerated tissue in the model group, which increased following treatment with Zizhu ointment. The mean microvascular density in the Zizhu ointment group was significantly higher than that in both the model group and the saline-treated group (P < 0.05). (4) Compared with the control group, the model group displayed downregulated vascular endothelial growth factor A and angiopoietin-2 expression (P < 0.01) along with upregulated sprouty-related EVH1 domain-containing protein 1 and phosphoinositide 3-kinase regulatory subunit 2 levels (P < 0.001). Compared with the model and saline-treated groups, Zizhu ointment significantly increased vascular endothelial growth factor A and angiopoietin-2 expression (P < 0.05) while reducing the expression of sprouty-related EVH1 domain-containing protein 1 and phosphoinositide 3-kinase regulatory subunit 2 (P < 0.05 or P < 0.01). To conclude, streptozotocin-induced diabetic foot ulcer mice exhibit delayed wound healing accompanied by impaired neovascularization. Treatment with Zizhu ointment significantly accelerates ulcer healing, promotes angiogenesis, and modulates the expression of angiogenesis-related genes and proteins. Our preliminary results indicate that topical application of Zizhu ointment facilitates the healing of diabetic ulcers in mice, potentially through its regulatory effects on wound angiogenesis.
    Figures and Tables | References | Related Articles | Metrics
    Exercise combined with magnetic stimulation improves muscle strength and gait speed in patients with disuse-induced muscle atrophy of the lower limbs
    Sun Shiqiang, Bai Shi, Li Wenhao, Wang Youpeng, Du Xinran, Zhang Hao, Li Zhongshan
    2026, 30 (35):  9189-9197.  doi: 10.12307/2026.231
    Abstract ( 35 )   PDF (2417KB) ( 9 )   Save
    BACKGROUND: In recent years, magnetic stimulation therapy can activate the classical transient receptor potential channel 1, triggering the calcium-mitochondrial axis to enhance myogenesis and mitochondrial biogenesis in vivo, thereby recapitulating physiological adaptations related to exercise-induced metabolic responses. As an emerging technique for promoting muscle function, magnetic stimulation has gained widespread attention and validation in the rehabilitation of muscular diseases due to its advantages of being non-invasive, passive, and safe. However, there is a lack of clinical studies on the therapeutic efficacy of this technique in the treatment of disuse-induced muscle atrophy.
    OBJECTIVE: To investigate the therapeutic effect of exercise therapy combined with magnetic stimulation on the recovery of muscle strength and locomotor ability in patients with disuse-induced muscle atrophy after Achilles tendon rupture.
    METHODS: Sixteen patients were recruited for long-term bed rest after unilateral Achilles tendon rupture of the lower limb, which triggered disuse-induced muscle atrophy of the lower limbs. These patients were randomly divided into a control group and an experimental group, with eight cases in each group. The control group received traditional exercise rehabilitation therapy, including joint mobility training, muscle strength training, soft tissue stretching training, three times a week; the experimental group was subjected to medical magnetic physical factor stimulation (intensity 1.5 mT, frequency 3 300 Hz, once for 10 minutes every 48 hours) based on the exercise training. The total length of the trial was 4 weeks. All subjects were tested for maximum voluntary contraction force of the lower limbs and gait speed indexes (including the Timed Up and Go Test, the 5 Times Sit-to-Stand Test, and the 6-Meter Walking Test) before and after the intervention. Changes in these indexes were observed.
    RESULTS AND CONCLUSION: (1) After 4 weeks of intervention, 16 subjects completed the trial. In the experimental group, the maximum voluntary contraction force of the lower limb on the affected side (P=0.001) and the discrepancy rate of maximum voluntary contraction force between the healthy and affected sides decreased significantly (P=0.001); both changes were significantly better than those in the control group. (2) In terms of gait speed indexes, the experimental group showed significant improvement in the Timed Up and Go Test (P=0.038), the 5 Times Sit-to-Stand Test (P=0.050), and the 6-Meter Walking Test (P=0.025) after intervention. (3) Inter-group comparisons revealed that the experimental group showed significant improvements compared with the control group in the following parameters: maximum voluntary contraction of the affected lower limb (P=0.003), discrepancy rate of maximum voluntary contraction between the unaffected and affected sides (P=0.004), Timed Up and Go Test results (P=0.019), and 6-Meter Walking Test results (P=0.011). The above data confirmed that after 4 weeks of low-frequency pulsed magnetic field (1.5 mT, 3 300 Hz) combined with exercise therapy, patients with postoperative disuse-induced muscle atrophy after Achilles tendon rupture had a significantly better improvement than the control group in the maximum voluntary contraction force of the affected limb, Timed Up and Go Test results, and 6-Meter Walking Test results, which could indicate that magnetic stimulation combined with exercise therapy can produce synergistic enhancement effects on isometric muscle strength and lower limb motor function. Therefore, the combination of magnetic stimulation and exercise therapy can be considered as a novel approach for the recovery of disuse-induced muscle atrophy.

    Figures and Tables | References | Related Articles | Metrics
    Transcriptomic analysis of the mechanism of electroacupuncture in alleviating early synovial inflammation in a rat model of knee osteoarthritisbr#
    Wen Xing, Li Mengmeng, Jia Feiyang, Qu Mengjian, Sun Guanghua, Liu Jing, Huang Xiarong, Zhong Peirui, Wang Jinling, Zhou Jun
    2026, 30 (35):  9198-9205.  doi: 10.12307/2026.466
    Abstract ( 36 )   PDF (2378KB) ( 12 )   Save
    BACKGROUND: Early synovial inflammation plays a crucial role in the onset and progression of knee osteoarthritis and has become a significant focus for research and intervention in joint disorders. Electroacupuncture, as a commonly used physical intervention, lacks a systematic molecular-level explanation of its mechanism in synovial tissue. Analyzing the gene expression profile of synovial tissue using transcriptomic technology helps reveal the key signaling pathways and targets regulated by electroacupuncture, providing a theoretical basis and data support for early intervention in osteoarthritis.
    OBJECTIVE: To investigate the effect of electroacupuncture on early synovial inflammation in a rat model of knee osteoarthritis based on transcriptomic sequencing technology.
    METHODS: Twenty-four 3-month-old male Sprague-Dawley rats were randomly divided into a control group, a model group, and an electroacupuncture group, with eight rats in each group. The model group and electroacupuncture group underwent anterior cruciate ligament transection to induce the knee osteoarthritis model, while the control group did not. Four weeks after modeling, the electroacupuncture group received electroacupuncture at bilateral “Zusanli” (ST 36), “Xuehai” (SP 10), “Taixi” (KI 3), and “Yanglingquan” (GB 34). The parameters were: sparse-dense wave at 3 Hz/15 Hz, current intensity of 
    1 mA, 30 minutes per session, once daily, 5 days per week, for a total of 2 weeks. After the intervention, the synovium of the left knee joint was collected for mRNA sequencing, and the right knee joint was subjected to safranin O-fast green staining and Mankin’s scoring.
    RESULTS AND CONCLUSION: (1) Compared with the control group, the model group showed rough cartilage surfaces and disordered synovial cell arrangement, with increased Mankin's scores (P < 0.001). Compared with the model group, the electroacupuncture group exhibited smoother cartilage surfaces, reduced inflammatory infiltration in synovial tissue, and decreased Mankin’s scores (P < 0.05). (2) There were 29 genes upregulated in the synovial tissue of the model group and downregulated in the electroacupuncture group, and 19 genes downregulated in the model group and upregulated in the electroacupuncture group. (3) Gene Ontology analysis indicated that the main functions of these differentially expressed genes were enriched in MHC protein complex binding, protein homodimerization activity, and BH3 domain binding. Kyoto Encyclopedia of Genes and Genomes pathway analysis showed that the differentially expressed genes were primarily enriched in cell adhesion molecules, the phosphatidylinositol 3-kinase-protein kinase B (PI3K-Akt) signaling pathway, the nuclear factor kappa B signaling pathway, and the peroxisome proliferator-activated receptor signaling pathway. (4) Compared with the control group, the mRNA expression of Myh9, Hmox1, and S100a8 in synovial tissue was significantly increased in the model group (P < 0.001, P < 0.001, P < 0.001), while the mRNA expression of Rack1 and Ddit3 was significantly decreased (P < 0.01, P < 0.001). Compared with the model group, the mRNA expression of Myh9, Hmox1, and S100a8 in synovial tissue was significantly decreased in the electroacupuncture group (P < 0.05, P < 0.001, P < 0.001), while Ddit3 mRNA expression was significantly increased (P < 0.001), and Rack1 mRNA expression showed an increasing trend, but the difference was not statistically significant (P > 0.05). Real-time quantitative PCR results were largely consistent with the gene sequencing results. These findings indicate that electroacupuncture can significantly alleviate early synovial inflammation in rats with knee osteoarthritis, which may be related to inhibiting the expression of Myh9, Hmox1, and S100a8 and promoting the expression of Rack1 and Ddit3 in synovial tissue.
    Figures and Tables | References | Related Articles | Metrics
    MicroRNA-23a-3p improves neurological function in mice with traumatic brain injury by regulating microglial polarization
    Li Xiaoyan, Li Jinglin, Zhang Qiujuan, Zhang Xiaolina, Yang Li
    2026, 30 (35):  9206-9216.  doi: 10.12307/2026.281
    Abstract ( 34 )   PDF (1816KB) ( 19 )   Save
    BACKGROUND: Previous studies have demonstrated neuroprotective potential of microRNA-23a-3p in traumatic brain injury. However, direct evidence is still lacking regarding whether this protective effect stems from its precise regulation of the M1/M2 polarization balance of microglia.
    OBJECTIVE: To clarify the expression changes of microRNA-23a-3p in mouse brain tissue after traumatic brain injury and to explore the specific mechanism by which it affects neurological function through regulating microglial polarization.
    METHODS: Eighty C57BL/6J mice were randomly assigned to four groups: a sham operation group (sham group), a traumatic brain injury group, a traumatic brain injury + agomir-NC group, and a traumatic brain injury + agomir-microRNA-23a-3p group. The traumatic brain injury group used the cortical impact method to establish the severe traumatic brain injury model. The sham group did not undergo cortical impact treatment. The intervention groups were given intraventricular injection of agomir-NC or agomir-microRNA-23a-3p after modeling. For the sham and traumatic brain injury groups, six rats were sampled at 1, 3, 7, and 14 days post-modeling, respectively; six rats from each of the remaining two groups were sampled at 14 days post-modeling. The neurological deficits were evaluated by modified neurological severity score. Hematoxylin-eosin staining and Nissl staining were used to observe the pathological damage of brain tissue and neurons. qRT-PCR and western blot assay were performed to detect the levels of microRNA-23a-3p, the expression of M1 (CD16, CD86) and M2 (CD206, Arginase-1) phenotypic markers in microglia, as well as the mRNA and protein expression of the inflammatory factors tumor necrosis factor-alpha and interleukin-10 in mouse brain tissue. Immunohistochemical staining was used to further assess the M1/M2 polarization status of microglia and to observe the aggregation of F4/80 positive cells in the damaged area.
    RESULTS AND CONCLUSION: Compared with the sham group, the expression of microRNA-23a-3p in the brain tissue of the traumatic brain injury group showed a “V” shaped curve change, with downregulation in the early stage of injury and upregulation starting 7 days after the injury. Upregulation of microRNA-23a-3p could reduce the modified neurological severity score of traumatic brain injury mice. Morphological results showed that upregulation of microRNA-23a-3p alleviated brain tissue edema and neuronal damage. Molecular biology detection results showed that upregulation of microRNA-23a-3p promoted microglia polarization from M1 type to M2 type. These findings indicate that microRNA-23a-3p promotes the recovery of neurological function in mice after traumatic brain injury by regulating microglial polarization.

    Figures and Tables | References | Related Articles | Metrics
    Regulatory effects of Yuping Shen’an Granules on neuronal autophagy in a mouse model of insomnia
    Wang Yuhe, Xie Tianyu, Ma Shijia, Wang Yujiao, Li Mengting, Xie Daojun
    2026, 30 (35):  9217-9230.  doi: 10.12307/2026.254
    Abstract ( 44 )   PDF (16557KB) ( 10 )   Save
    BACKGROUND: Modern medicine often uses benzodiazepines for the treatment of insomnia complicated by anxiety; however, long-term use can lead to drug dependence and adverse reactions. Traditional Chinese medicine, based on syndrome differentiation and holistic treatment, demonstrates definite efficacy and high safety, offering multi-pathway and multi-target comprehensive effects, thereby providing new ideas and directions for the treatment of this condition.
    OBJECTIVE: To investigate the effects of Yuping Shen’an Granules on hippocampal neuronal autophagy in a mouse model of insomnia complicated by anxiety via the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway.
    METHODS: The components of Yuping Shen’an Granules were identified using ultra-performance liquid chromatography-mass spectrometry, and key pathways were predicted through network pharmacology. Ninety male C57BL/6J mice were randomly divided into nine groups (n=10 per group): normal group, model group, low-, medium-, and high-dose Yuping Shen’an groups [3.125, 6.25, and 12.5 g/(kg·d)], eszopiclone group [0.06 mg/(kg·d)], verification experiment-model group, verification experiment-model + PI3K inhibitor [10 mg/(kg·d)] group, and verification experiment-Yuping Shen’an [12.5 g/(kg·d)] + PI3K inhibitor [10 mg/(kg·d)] group. All groups except for the normal group underwent 2 weeks of chronic unpredictable mild stress and 4 days of intraperitoneal injection of p-chlorophenylalanine to establish a mouse model of insomnia complicated by anxiety. Behavioral assessments were conducted using the open field test and pentobarbital sodium-induced sleep test. Pathological changes in the hippocampus were observed via hematoxylin-eosin staining and Nissl staining. Serotonin, γ-aminobutyric acid, dopamine, and norepinephrine levels were measured using enzyme-linked immunosorbent assay. LC3B expression was detected through immunofluorescence staining. The Western blot assay was employed to measure the expression of proteins associated with the PI3K/Akt/mTOR pathway and autophagy-related proteins (P62, Beclin-1, LC3B), as well as the serotonin 1A receptor. The number of autophagosomes was quantified using a transmission electron microscope.  
    RESULTS AND CONCLUSION: Ultra-performance liquid chromatography-mass spectrometry identified 2 276 components, with 35 major components screened. Network pharmacology analysis indicated the PI3K/Akt/mTOR pathway as a potential target. Compared with the normal group, the model group exhibited increased exploratory behavior, prolonged sleep latency (P < 0.01), significant hippocampal neuronal damage, decreased levels of serotonin and γ-aminobutyric acid, and increased levels of dopamine and norepinephrine (P < 0.01). Additionally, there was upregulation of LC3B fluorescence and protein expression (P < 0.01), downregulation of phosphorylated PI3K/Akt/mTOR, P62, and the serotonin 1A receptor, and upregulation of Beclin-1 and LC3B (P < 0.05), along with an increased number of autophagosomes. Compared with the model group, the verification experiment-model + PI3K inhibitor group exhibited aggravated damage, while the high-dose Yuping Shen’an group and the verification experiment-Yuping Shen’an + PI3K inhibitor group significantly reversed these changes. They improved behavioral indicators, alleviated neuronal damage, increased levels of serotonin and γ-aminobutyric acid, and decreased levels of dopamine and norepinephrine (P < 0.05). Additionally, they modulated the expression of autophagy-related proteins (P < 0.05) and reduced the number of autophagosomes. These findings indicate that Yuping Shen’an Granules improve symptoms of insomnia complicated by anxiety by activating the PI3K/Akt/mTOR pathway, regulating neurotransmitter balance, and inhibiting excessive autophagy in hippocampal neurons.
    Figures and Tables | References | Related Articles | Metrics
    Applications and advances of tissue/organ perfusion
    Yuan Yue, Chang Guoxin, Lin Dingmei, Mo Zixuan, Yu Jingjing, Zhu Yixia, Zheng Zhaoguang, Wang Yan
    2026, 30 (35):  9231-9238.  doi: 10.12307/2026.300
    Abstract ( 35 )   PDF (2009KB) ( 15 )   Save
    BACKGROUND: As critical physiological and functional units, tissue/organ have been utilized in experimental perfusion research for over two centuries. Today, perfusion technology is widely applied in various fields, including the screening of bioactive components in traditional Chinese medicine, pharmacodynamics and mechanisms, pharmacokinetics, pathological mechanisms, local cancer therapy, tissue/organ transplantation, tissue/organ fixation, cell preparation, and metabolite production. 
    OBJECTIVE: To summarize the experimental methods, influencing factors, and recent advances in tissue/organ perfusion technology, providing a reference for its practical application.
    METHODS: Relevant articles published from inception to September 2025 were retrieved and analyzed from the CNKI and PubMed databases using Chinese search terms “cardiac perfusion, cerebral perfusion, liver perfusion, kidney perfusion, intestinal perfusion, lung perfusion, nerve perfusion, limb perfusion” and English search terms “heart perfusion/cardiac perfusion, brain perfusion, liver perfusion, kidney perfusion, intestinal perfusion, lung perfusion, neural perfusion/nerves perfusion, limb perfusion, forelimb perfusion, hindlimb perfusion, rat, rabbit.” After excluding clinical trials, duplicate and irrelevant articles, a total of 86 articles were selected for comprehensive review. 
    RESULTS AND CONCLUSION: (1) Tissue/organ perfusion technology serves as an essential bridge between cellular experiments and whole-animal studies, providing a controlled platform that allows for precise control of experimental conditions and avoids interference from complex in vivo factors. It holds a vital position in basic and applied research in life sciences. (2) While perfusion protocols share common operational steps across different tissue/organ, their successful application relies on parameter optimization, such as perfusion solution composition and flow rate, tailored to the specific physiological and anatomical characteristics of each organ, reflecting a principle of unified fundamentals with context-specific implementations. (3) Perfusion technology is applied across a wide range of fields, from drug development to pathological mechanism exploration. Its applications are highly targeted; for example, intestinal perfusion is used to study drug absorption, liver perfusion for metabolic research, and kidney perfusion for excretion mechanisms, leveraging the unique physiological functions of each target organ. (4) Perfusion technology continues to evolve, progressing from classical models such as the Langendorff system to more physiologically relevant setups like the working heart model. It is increasingly being integrated with advanced technologies such as transgenic animal models, organ-on-a-chip, and organoids, driving the field toward greater precision and human relevance.
    Figures and Tables | References | Related Articles | Metrics
    Type VI collagen: a multifunctional regulator in bone homeostasis and tissue engineering
    Dong Shiming, Xie Zhenzi, Tao Rongrong, Mardan·Mamat, Ma Hairong
    2026, 30 (35):  9239-9247.  doi: 10.12307/2026.468
    Abstract ( 39 )   PDF (2107KB) ( 17 )   Save
    BACKGROUND: As a key structural protein in the extracellular matrix, type VI collagen plays a critical role in skeletal development, homeostasis, and repair through its unique tetrameric microfibrillar network. Recent studies have revealed that aberrant expression of type VI collagen is closely associated with skeletal diseases such as osteoporosis, osteoarthritis, and bone tumors. However, its multidimensional regulatory mechanisms and translational potential remain to be systematically summarized.
    OBJECTIVE: To summarize the structural characteristics and biological functions of type VI collagen in the skeletal system, elucidate its role in the pathogenesis of skeletal diseases, and explore its translational applications, including the development of biomarkers, construction of tissue-engineered materials, and design of therapeutic targets.
    METHODS: A systematic literature search was conducted using databases including PubMed, Web of Science, Elsevier ScienceDirect, and CNKI for relevant articles published from January 1982 to May 2025. Original research and review articles were included, while duplicates and low-quality publications were excluded. Ultimately, 69 articles (68 in English and 1 in Chinese) were included for systematic content integration and analysis.
    RESULTS AND CONCLUSION: Type VI collagen influences skeletal health through a tripartite regulatory network: (1) Bone formation and resorption balance: it promotes matrix bridge-mediated osteoblast connectivity and inhibits osteoclast activation via the tumor necrosis factor-α/nuclear factor-κB p65 subunit signaling pathway; (2) Disease mechanisms: in osteoporosis, the α2 chain of type VI collagen is epigenetically suppressed by microRNA-128-2-5p; in early-stage osteoarthritis, pericellular matrix degradation occurs; in bone tumors, the α1 chain is highly expressed; (3) Translational applications: type VI collagen enhances the osteogenic efficacy of scaffold materials; its specific serum degradation products serve as diagnostic biomarkers for fibrotic diseases; antisense oligonucleotide technology has been successfully applied to correct aberrant splicing caused by splice-site mutations. Type VI collagen serves as a central hub in maintaining bone homeostasis by integrating structural support and signaling functions within the extracellular matrix, thereby regulating the dynamic balance between bone formation and resorption. Its degradation products and tissue distribution patterns offer novel diagnostic biomarkers for skeletal diseases, while gene-targeted therapies and type VI collagen-enhanced scaffolds represent promising innovative strategies for treating osteoporosis and bone defects. Future research should focus on overcoming technical challenges in tissue-targeted delivery and advancing dynamic expression profiling based on multi-omics approaches.

    Figures and Tables | References | Related Articles | Metrics
    Molecular mechanism of icariin in prevention and treatment of osteoporosis
    Zhu Lifeng, Wang Wenchi, Liu Qiang, Cui Xianqin, Zhang Zhenhao, Huang Jie, Lyu Zhucheng, Wang Leihang, Cui Wei
    2026, 30 (35):  9248-9257.  doi: 10.12307/2026.283
    Abstract ( 41 )   PDF (5918KB) ( 16 )   Save
    BACKGROUND: Pharmacodynamic characteristics and mechanisms of action of icariin in combating osteoporosis gradually gain recognition within the academic community. Related basic research and clinical translation efforts are increasingly becoming the focal point of research. 
    OBJECTIVE: To summarize the research progress of icariin on anti-osteoporosis.
    METHODS: China National Knowledge Infrastructure (CNKI) and PubMed databases were searched for relevant literature. Chinese and English search terms included “icariin, osteoporosis, Chinese medicine compound, pathogenesis, signal path, BMSCs, osteoblast, osteoclast.” Based on inclusion criteria, 90 articles were ultimately included in the review. 
    RESULTS AND CONCLUSION: Icariin treatment increased alkaline phosphatase activity and induced the expression of core binding factor α1, bone morphogenetic protein 2, and bone morphogenetic protein 4 in bone marrow mesenchymal stem cells in a dose-dependent manner. Icariin promoted osteocalcin secretion at the fracture site and accelerated fracture healing by increasing serum levels of osteocalcin, bone-specific alkaline phosphatase, type I collagen N-terminal peptide, type I collagen C-terminal peptide, and tartrate-resistant acid phosphatase 5b in serum. Icariin achieved the proliferation and osteoblast differentiation of bone marrow mesenchymal stem cells in ovariectomized osteoporotic rats by upregulating alkaline phosphatase and osteocalcin levels and inhibiting the expression of Notch1, CBF1, and Jagged-1 proteins in the Notch pathway. This results in the prevention and treatment of osteoporosis. Icariin regulated bone metabolism through multiple signaling axes, including Wnt/β-catenin, mitogen-activated protein kinase, phosphatidylinositol 3-kinase/protein kinase B, osteoprotegerin/nuclear factor κB receptor activator ligand/nuclear factor κB receptor activator, and Notch. The Wnt/β-catenin pathway and the osteoprotegerin/nuclear factor κB receptor activator ligand/nuclear factor κB axis constitute the core regulatory mechanism, synergistically regulating the osteogenic-osteoclast balance. Icariin can influence the biological behavior of osteoblasts, osteoclasts, and bone marrow mesenchymal stem cells through multi-dimensional interventions, such as regulating mRNA expression modification, inhibiting oxidative stress, and improving the inflammatory microenvironment.
    Figures and Tables | References | Related Articles | Metrics
    Molecular mechanism by which the imbalance of the functional network of tissue inhibitors of metalloproteinases drives intervertebral disc degeneration
    Xiao Yang, Gao Zibo, Hu Yuxiang, Kang Zhixin, Zhang Chaoxuan, Huang Chengyu, Liu Honglin, Chen Kai, Wang Hongshen, Li Yongjin
    2026, 30 (35):  9258-9268.  doi: 10.12307/2026.278
    Abstract ( 36 )   PDF (1667KB) ( 10 )   Save
    BACKGROUND: Intervertebral disc degeneration is a core pathological mechanism of discogenic diseases, characterized by an imbalance in extracellular matrix metabolism. Tissue inhibitors of metalloproteinases, as endogenous antagonists of matrix metalloproteinases, play a crucial role in regulating extracellular matrix homeostasis in intervertebral disc degeneration. However, the subtype-specific functions, signal pathway interactions, and epigenetic regulatory mechanisms of tissue inhibitors of metalloproteinases have not been systematically elucidated.
    OBJECTIVE: To review the expression changes, functional heterogeneity, and regulatory networks of tissue inhibitors of metalloproteinases in intervertebral disc degeneration, with a focus on clarifying the molecular mechanisms and signaling pathways of tissue inhibitors of metalloproteinases in oxidative stress, mechanical loading, and inflammatory microenvironments, and to evaluate the translational potential of strategies such as tissue inhibitors of metalloproteinase-based gene therapy.
    METHODS: The first author conducted a literature search in PubMed, Web of Science, Embase, CNKI, and WanFang databasdes. The search period was from database inception to March 2025. The search terms included “intervertebral disc degeneration, intervertebral disc degenerative changes, intervertebral disc degeneration, tissue inhibitors of metalloproteinases, signaling pathways” in Chinese and “tissue inhibitor of metalloproteinases, tissue inhibitor of metalloproteinase, TIMPs, intervertebral disc degeneration, disc degeneration, degenerative disc disease, degenerative intervertebral discs” in English. A total of 76 articles that met inclusion criteria were selected for review.
    RESULTS AND CONCLUSION: (1) Functions of tissue inhibitor of metalloproteinase subtypes: Tissue inhibitor of metalloproteinase-1 exhibits dynamic bi-directional regulation (early protection/late depletion). Tissue inhibitor of metalloproteinase-2 maintains extracellular matrix homeostasis through inhibition of matrix metalloproteinase activity, and its aberrant expression can activate pro-apoptotic signaling pathways (such as the miR-185-5p/matrix metalloproteinase-2 axis and the inflammatory factor-mediated matrix metalloproteinase/tissue inhibitors of metalloproteinase imbalance). Tissue inhibitor of metalloproteinase-3 plays a multi-dimensional protective role through inhibition of matrix metalloproteinases activity, tumor necrosis factor alpha converting enzyme/tumor necrosis factor alpha axis, and vascular neogenesis. Tissue inhibitor of metalloproteinase-4 is regulated by miR-155-5p/fibroblast growth factor-2 to participate in the extracellular matrix homeostasis. (2) Epigenetic reprogramming mechanism: Abnormal mechanical stress degrades tissue inhibitors of metalloproteinas-3 mRNA through the WTAP/YTHDF2-m6A axis, whereas miR-222 targeted inhibition of tissue inhibitors of metalloproteinas-3 translation synergistically accelerates extracellular matrix degradation. (3) Multimodal therapeutic strategy: Photobiomodulation (wavelength-specific modulation of tissue inhibitors of metalloproteinase/matrix metalloproteinase), stem cell-derived exosomes (miR-199a/GREM1 axis) and irisin intervention can reconfigure matrix metabolic balance. The present review proposes a theoretical framework of "functional network imbalance of tissue inhibitors of metalloproteinases", reveals its multi-level regulation as a core driver of intervertebral disc degeneration, and lays the theoretical foundation for developing precise treatments that target epigenetic modifications and mechano-biological coupling interventions.
    Figures and Tables | References | Related Articles | Metrics
    Exercise improves neuropathic pain: precision exercise prescription and multimodal synergy advance clinical applications
    Guo Feng, Li Qian, Hou Chaowen, Guo Chengji
    2026, 30 (35):  9269-9280.  doi: 10.12307/2026.448
    Abstract ( 43 )   PDF (3053KB) ( 7 )   Save
    BACKGROUND: Neuropathic pain is a chronic pain condition caused by direct damage or functional abnormalities in the somatic sensory nervous system. Its clinical manifestations include spontaneous pain and tactile hypersensitivity, which are difficult to control effectively with traditional drug therapies. The pathogenesis of neuropathic pain involves multiple physiological processes, including neuronal hyperexcitability, glial cell activation, neurotransmitter imbalance, immune responses, and oxidative stress. Existing medications and invasive treatments often carry side effects and exhibit significant limitations in efficacy. Therefore, exploring safe and effective non-pharmacological interventions, particularly exercise-based interventions for improving neuropathic pain, has become a critical research focus in the field of neuropathic pain. 
    OBJECTIVE: To review advances in understanding the mechanisms of neuropathic pain, analyze the potential and mechanisms of exercise intervention in alleviating neuropathic pain, demonstrate the clinical application prospects of exercise as a non-pharmacological intervention strategy, and highlight key directions for future research.
    METHODS: Relevant literature was retrieved from databases including PubMed and CNKI using the keywords of “neuropathic pain, neurogenic pain, post-neuropathic pain, exercise, physical activity, aerobic exercise, strength training, yoga, pathogenesis, inflammation, neurotransmitters, neurotrophic factors, oxidative stress, rehabilitation” in Chinese and “neuropathic pain, nerve injury pain, exercise, physical activity, aerobic exercise, resistance training, yoga, pathogenesis, inflammation, neurotransmitter, neurotrophin, oxidative stress, rehabilitation” in English. A total of 139 studies were ultimately included in the analysis, focusing on the core mechanisms of neuropathic pain. The review specifically examined the mechanisms by which exercise alleviates neuropathic pain through multi-targeted, multi-pathway synergistic effects.
    RESULTS AND CONCLUSION: The pathogenesis of neuropathic pain involves neuronal hyperexcitability, glial cell activation, neurotransmitter imbalance, immune-inflammatory responses, and oxidative stress-induced nerve damage. Exercise intervention relieves pain by regulating pathways such as modulating neurotransmitter release, promoting neurotrophic factor expression, suppressing inflammatory responses, and mitigating oxidative stress. Specifically, exercise can upregulate neurotrophic factors such as brain-derived neurotrophic factor and nerve growth factor, while inhibiting the release of pro-inflammatory factors such as tumor necrosis factor, thereby modulating core pathways in neuropathic pain development. Simultaneously, it produces analgesic effects by modulating the endogenous opioid system. However, the specific mechanisms by which different exercise modalities alleviate neuropathic pain require further investigation. Significant challenges remain in designing personalized exercise prescriptions and optimizing exercise parameters. Future research should focus on developing and validating exercise protocols, clarifying synergistic effects of exercise combined with pharmacotherapy, and thereby advancing clinical treatment for neuropathic pain.

    Figures and Tables | References | Related Articles | Metrics
    Mechanism by which non-apoptotic regulated cell death induces neuronal injury in ischemic stroke
    Su Xu, Zhang Xiaoxi, Yang Yaqing, Fu Zhenyi, Liu Jiaxin
    2026, 30 (35):  9281-9293.  doi: 10.12307/2026.257
    Abstract ( 39 )   PDF (2171KB) ( 13 )   Save
    BACKGROUND: In recent years, the involvement of non-apoptotic regulated cell death in the development of ischemic stroke has become a research hotspot.
    OBJECTIVE: To summarize the roles and action mechanisms of non-apoptotic regulated cell death subroutines such as autophagy, ferroptosis, cuproptosis, disulfidptosis, necroptosis, and pyroptosis in the neuronal damage caused by ischemic stroke.
    METHODS: Relevant literature on non-apoptotic regulated cell death and ischemic stroke was retrieved from the China National Knowledge Infrastructure and PubMed databases. The search terms included “ischemic stroke, regulated cell death, autophagy, ferroptosis, cuproptosis, disulfidptosis, necroptosis, pyroptosis, alkaliptosis, oxeiptosis, parthanatos, mitochondrial permeability transition-driven necrosis, neutrophil extracellular trap-related death, lysosome-dependent cell death, immunogenic cell death, anoikis” in both Chinese and English. Based on the inclusion criteria, a total of 176 articles were selected for analysis and summary.
    RESULTS AND CONCLUSION: The regulatory mechanisms of non-apoptotic regulated cell death mainly include autophagy, ferroptosis, anoikis, cuproptosis, disulfidptosis, necroptosis, pyroptosis, oxeiptosis, alkaliptosis, parthanatos, mitochondrial permeability transition-driven necrosis, neutrophil extracellular trap-related death, lysosome-dependent cell death, and immunogenic cell death. Autophagy plays a dual regulatory role in the damage of neural cells caused by ischemic stroke. Under ischemic conditions, autophagy exerts a protective effect on neural cells, while in the reperfusion stage, excessive autophagy can lead to the death of neural cells. Ferroptosis can promote the damage of neural cells in ischemic stroke through iron overload and lipid peroxidation. The cuproptosis regulatory ferredoxin-1 protein can induce ferroptosis by regulating glutathione. There is partial crosstalk between disulfidptosis and ferroptosis. Under conditions of glucose deficiency, the upregulation of solute carrier family 7 member 11 (SLC7A11) will consume nicotinamide adenine dinucleotide phosphate (NADPH), leading to abnormal accumulation of disulfide compounds and promoting the occurrence of neural cell disulfidptosis. Necroptosis, an important participant, is also related to the activation of the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome, a protein-related protein of pyroptosis, and can further promote pyroptosis of neural cells during the occurrence of necroptosis in ischemic stroke. The neutrophil extracellular trap-related death associated with ischemic stroke mainly occurs through citrullination and the formation of stress-triggered neutrophil extracellular traps, mediated by various cytotoxic proteases, leading to an inflammatory response. Other emerging subtypes of immunogenic cell death cause damage to neural cells in ischemic stroke in various specific ways.

    Figures and Tables | References | Related Articles | Metrics
    Efficacy and safety of romozumab in the treatment of osteoporosis in adults: a meta-analysis
    Wang Xiaochen, Guo Lin, Wang Changcheng, Xu Tan, Gu Mingxi
    2026, 30 (35):  9294-9301.  doi: 10.12307/2026.469
    Abstract ( 67 )   PDF (5392KB) ( 59 )   Save
    OBJECTIVE: Romosozumab is a novel biologic agent currently being used to treat osteoporosis in postmenopausal women at high risk of fracture. This meta-analysis aims to systematically evaluate the efficacy and safety of romosozumab compared with placebo, alendronate sodium, teriparatide, and denosumab in the treatment of osteoporosis in adults.
    METHODS: The medical keywords “anti-sclerostin antibody,” “romosozumab,” “AMG 78500,” and “osteoporosis” were used to search PubMed, CNKI, Web of Science, and the Cochrane Central Register of Controlled Trials (CENTRAL) for randomized controlled trials comparing the safety and efficacy of romosozumab with alendronate, teriparatide, denosumab, or placebo in adult patients with osteoporosis, published from database inception until July 1, 2025. Two researchers independently screened eligible studies, assessed the risk of bias, and extracted data from each study. The quality of the included randomized controlled trials was evaluated using the Cochrane Collaboration’s Risk of Bias Tool for Randomized Controlled Trials. Meta-analysis was performed using review management software (RevMan version 5.4). The primary outcome for assessing anti-osteoporotic efficacy was the percentage change in bone mineral density from baseline at 6 and 12 months. Secondary outcomes included the incidence of adverse events and cardiovascular complications during treatment with anti-osteoporotic medications.
    RESULTS: (1) A total of 10 randomized controlled trials involving 12 570 patients were included in the meta-analysis. (2) Compared with placebo, alendronate, and teriparatide, romosozumab significantly increased bone mineral density at the lumbar spine, total hip, and femoral neck at 6 and 12 months. Compared with denosumab, romosozumab significantly increased lumbar spine bone mineral density at 6 months (mean difference [MD]=3.68, 95% confidence interval [CI]: 0.34–7.01, P=0.03) and 12 months (MD=5.20, 95% CI: 3.19–7.21, P < 0.000 01), while no significant differences were observed in total hip or femoral neck bone mineral density at 6 and 12 months between the two treatments. (3) In terms of safety, compared with the alendronate subgroup, romosozumab had a lower incidence of adverse events (relative risk [RR]=0.96, 95% CI: 0.93-0.99, P=0.02); compared with the teriparatide subgroup, romosozumab had a higher incidence of adverse events (RR=1.13, 95% CI: 1.01–1.25, P=0.03). There were no statistically significant differences in the incidence of adverse events between romosozumab and placebo (RR=0.98, 95% CI: 0.96–1.00, P=0.11) or denosumab (RR=2.64, 95% CI: 0.74–9.36, P=0.13). (4) Most importantly, romosozumab did not significantly increase the risk of cardiovascular complications compared with other treatments (RR=1.25, 95% CI: 0.94-1.67, P=0.12).
    CONCLUSION: Romosozumab can rapidly improve lumbar spine bone mineral density with an overall controllable safety profile, making it particularly suitable for adult osteoporosis patients at high fracture risk who require rapid bone mass improvement and have no cardiovascular contraindications. This meta-analysis is based on limited data and has certain limitations. More high-quality, longer-term follow-up studies are needed to validate these findings.

    Figures and Tables | References | Related Articles | Metrics
    Effects of exercise intervention on cortical excitability and motor performance in healthy populations: a meta-analysis based on transcranial magnetic stimulation measurements
    Li Lei, Zhao Qisheng
    2026, 30 (35):  9302-9308.  doi: 10.12307/2026.442
    Abstract ( 43 )   PDF (3328KB) ( 14 )   Save
    OBJECTIVE: Multiple studies have confirmed that exercise interventions can induce changes in cortical excitability detectable by transcranial magnetic stimulation; however, the neural regulatory effects among different training types remain inconsistent, with no unified conclusions. Based on this, this study aims to systematically evaluate the effects of exercise interventions on cortical excitability and motor performance in healthy populations, exploring the underlying mechanisms at neurophysiological and motor functional levels.  
    METHODS: A systematic search was conducted in PubMed, Web of Science, Embase, Cochrane Library, and Chinese databases including CNKI, VIP, and WanFang. Randomized controlled trials and crossover trials involving healthy adults undergoing exercise interventions were included, where the trial group underwent any form of exercise intervention, while the control group received sham intervention or no exercise intervention. Outcome measures included cortical excitability indexes and motor performance assessed via transcranial magnetic stimulation. Meta-analysis was performed using RevMan 5.4 software, with subgroup and sensitivity analyses conducted to further explore sources of heterogeneity.
    RESULTS: A total of 15 studies (380 participants) were included. Meta-analysis results indicated that exercise interventions had significant positive effects on both cortical excitability and motor performance. Exercise interventions significantly enhanced cortical excitability [standard mean difference (SMD)=0.38, 95% confidence interval (CI)=(0.05, 0.72), P=0.03], with a small-to-moderate effect size. Exercise interventions also significantly improved motor performance [SMD=0.42, 95% CI (0.07, 0.76), P=0.02], with a moderate effect size. Subgroup analysis revealed that strength training had the most significant effect on enhancing cortical excitability [SMD=0.53, 95% CI (0.12, 0.94), P=0.01], whereas motor skill training [SMD=-0.29, 95% CI (-1.13, 0.55), P=0.50], high-intensity interval training [SMD=0.04, 95% CI (-0.44, 0.53), P=0.86], and balance training [SMD=0.45, 95% CI (-0.37, 1.26), P=0.28] did not reach statistical significance. Inter-study heterogeneity was relatively high, potentially attributable to differences in intervention types, training duration, or measurement indicators. Sensitivity analysis confirmed the robustness of the results, and funnel plot analysis suggested a low risk of publication bias.  
    CONCLUSION: Exercise interventions can effectively enhance cortical excitability and motor performance in healthy populations, with strength training demonstrating particularly pronounced effects. Future research should delve deeper into the mechanisms of different training types, optimize training protocol designs to further improve neuroplasticity and motor performance outcomes.  
    Figures and Tables | References | Related Articles | Metrics
    Motor imagery-based brain-computer interface rehabilitation training improves upper limb motor function in stroke patients: a meta-analysis
    Guan Hui, Hou Wangjun, Fang Enhui, Chen Kang, Zhuang He
    2026, 30 (35):  9309-9315.  doi: 10.12307/2026.440
    Abstract ( 61 )   PDF (2637KB) ( 29 )   Save
    OBJECTIVE: To systematically evaluate the effects of motor imagery-based brain-computer training on upper limb motor function in patients with stroke, thereby providing evidence-based guidance for clinical practice. 
    METHODS: The randomized controlled trials about the effects of motor imagery-based brain-computer interface training in patients with stroke were retrieved from databases (PubMed, Web of Science, Embase, Cochrane Library, CBM, CNKI, VIP, and WanFang Data) from the establishment of the databases to July 2025. Two researchers independently conducted literature screening and data extraction. The Cochrane bias risk was used to evaluate the level of evidence. Rev Man 5.4 software was used for meta-analysis. 
    RESULTS: Eleven studies encompassing 543 stroke survivors were ultimately included. The results of the meta-analysis showed that the experimental group had better outcomes than the control group in terms of the Fugl Meyer assessment [mean difference (MD)=5.25, 95% confidence interval (CI) (3.28, 7.21), P < 0.000 01], Wolf Motor Function Test [MD=4.98, 95% CI (3.26, 6.69), P < 0.000 01], Modified Barthel Index [MD=9.53, 95% CI (5.99, 13.07), P < 0.000 01], motor evoked potential [MD=-0.64, 95% CI (-1.10, -0.18), P=0.006], and central motor conduction time [MD=-0.90, 95% CI (-1.36, -0.45), P=0.000 1]. Subgroup analysis revealed that patients who received brain-computer interface training for a period of ≥ 4 weeks showed more significant improvements in daily living abilities. Moreover, patients who underwent ≥ 20 sessions of training exhibited more pronounced improvements in upper limb motor function, suggesting that the more intervention sessions, the better the outcomes.
    CONCLUSION: Current evidence suggests that motor imagery-based brain-computer interface training has the best efficacy in improving upper limb motor function and daily living ability in stroke patients. Given the dual limitations of methodological heterogeneity and small sample sizes in current studies, large-scale, rigorously designed randomized controlled trials are required to validate these findings in the future.

    Figures and Tables | References | Related Articles | Metrics
    A visualized analysis of vagus nerve stimulation in the field of stroke rehabilitation
    Wang Xiaojing, Wei Jingyi, Liu Xihua
    2026, 30 (35):  9316-9326.  doi: 10.12307/2026.238
    Abstract ( 44 )   PDF (5193KB) ( 9 )   Save
    BACKGROUND: The vagus nerve stimulation technique enhances cortical excitability and neuroplasticity by stimulating the vagus nerve. Its application in stroke rehabilitation has received widespread attention. Currently, there is no study analyzing the research status and development trend of vagus nerve stimulation in the field of stroke rehabilitation.
    OBJECTIVE: To analyze the current development status, research hotspots, and development trends of vagus nerve stimulation in the field of stroke rehabilitation, in order to provide a reference for future research and optimization of clinical rehabilitation plans for stroke.
    METHODS: We retrieved relevant literature on the application of vagus nerve stimulation in stroke rehabilitation from China National Knowledge Infrastructure, WanFang, PubMed, and Web of Science Core Collection databases from January 1, 2012 to February 1, 2025. Using CiteSpace 6.3.R1 software, we performed visualized analyses of publication volumes, countries/regions and institutions, authors, keyword co-occurrence, keyword clustering, and keyword bursts.
    RESULTS AND CONCLUSION: A total of 297 articles were included, of which 86 were in Chinese and 211 were in English. The annual publication volume of vagus nerve stimulation in the field of stroke rehabilitation at home and abroad generally shows an upward trend. The country with the highest number of publications is China. The authors with the highest number of Chinese and English publications are Zhao Jingjun and Seth A. Hays, respectively. The institutions with the highest number of Chinese and English publications are Chongqing Medical University and the University of Texas System, respectively. Domestic and foreign universities are the main battlegrounds for scientific research achievements. Domestic research teams and institutions are more scattered than their international counterparts, and there is less cooperation among teams. Keyword co-occurrence and clustering results show that vagus nerve stimulation research mainly focuses on stroke, upper limb function, neuroplasticity, neuroprotective effects, etc. The bursting keywords are mainly motor function and cortical plasticity. The overall research direction mainly revolves around the effects of vagus nerve stimulation on motor, swallowing, cognitive and other functions post-stroke, as well as the exploration of mechanisms to improve neurological function. In the future, research in this field may focus on the application of non-invasive vagus nerve stimulation in stroke rehabilitation and combining vagus nerve stimulation technology with other rehabilitation techniques to explore their related mechanisms.

    Figures and Tables | References | Related Articles | Metrics
    Visualization analysis of literature on medication-related osteonecrosis of the jaw
    Wang Quan, Tang Zhenglong
    2026, 30 (35):  9327-9335.  doi: 10.12307/2026.413
    Abstract ( 36 )   PDF (3384KB) ( 16 )   Save
    BACKGROUND: Bibliometric and visualization analyses of theme-related literature on medication-related osteonecrosis of the jaw are essential for gaining a comprehensive understanding of its research foundation and emerging trends.
    OBJECTIVE: To reveal research hotspots, current status, and trends in medication-related osteonecrosis of the jaw through bibliometrics, citation analysis, and visualization analysis.
    METHODS: The top 100 most-cited medication-related osteonecrosis of the jaw research articles published between 2004 and 2024 were retrieved and screened from the Web of Science Core Collection (SCI-Expanded). A bibliometric analysis was conducted to extract and analyze core characteristics such as annual publication volume, countries, institutions, authors, journal sources, and co-citation relationships, followed by the use of CiteSpace 6.4.R1 software to generate knowledge maps, thereby identifying research hotspots and emerging trends.
    RESULTS AND CONCLUSION: The included literature accumulated a total of 12 337 citations, with an average annual citation rate of 6.17 citations per article. A stable and cohesive core international collaboration network exists. The United States, the University of London, and Professor Salvatore L. Ruggiero were the leading country, institution, and author, respectively, in contributing to the highly cited publications. Hotspot keywords primarily included risk factors, bisphosphonates, cancer, and osteoclasts, while “denosumab” emerged as a burst keyword, indicating a diversified research focus. Research interest in medication-related osteonecrosis of the jaw shows an overall upward trajectory, with a core focus on its pathological mechanisms, risk factors, and treatment strategies. High-level evidence, including large cohort studies (Level of Evidence [LOE] 2a), high-quality randomized controlled trials (LOE 1b), GRADE systematic reviews and meta-analyses, and clinical practice guidelines, has significantly advanced the field. Looking ahead, tissue engineering and regenerative medicine, encompassing the use of 3D-printed scaffolds, stem cell therapy, functionalized biomaterials, and in vitro models, are expected to provide breakthrough strategies for medication-related osteonecrosis of the jaw bone repair, regeneration, and mechanistic research.

    Figures and Tables | References | Related Articles | Metrics
    Postmenopausal cognitive impairment: a bibliometric analysis of developmental context and hot trends
    Chen Xiaoxia, Zhao Lihua, Li Taowen, Qin Yimei, Liang Jinyu
    2026, 30 (35):  9336-9344.  doi: 10.12307/2026.439
    Abstract ( 40 )   PDF (60130KB) ( 6 )   Save
    BACKGROUND: At present, there are few longitudinal studies on postmenopausal cognitive impairment, and there is no systematic bibliometric analysis of its development context and hot trends. 
    OBJECTIVE: To systematically integrate the related research on postmenopausal cognitive impairment with the help of bibliometric tools, identify the research trends and hot trends in this field, and promote interdisciplinary cooperation and clinical transformation. 
    METHODS: The Web of Science Core Collection database was retrieved for literature related to postmenopausal cognitive impairment published from January 1, 2005 to March 24, 2025. Visualization analysis was conducted using software such as VOSviewer, the R package “Bibliometrix,” and CiteSpace.
    RESULTS AND CONCLUSION: A total of 1 452 articles were included, involving 71 countries, 1 830 institutions, 510 journals, and 6 909 authors. The annual number of publications on postmenopausal cognitive impairment showed a fluctuating upward trend. The United States occupied an absolute dominant position in this field, with Stanford University, University of Pittsburgh, Harvard Medical School, and University of Illinois at the forefront. Menopause - The Journal of the North American Menopause Society had the highest number of publications (78 articles), while JAMA - Journal of the American Medical Association had the highest total number of citations (3 791 times). Espeland, Mark A. ranked first with 55 published articles; among the authors by total citations, Shumaker, Sally A. took the top spot (859 citations). From the high-frequency keyword "estrogen" (211 occurrences) and the burst keywords "progestogen addition" (strength = 15.77) and "estrogen replacement therapy" (strength = 15.57), it can be concluded that the long-term effects and safety of hormonal interventions have always been the core of research in this field. Keyword clustering revealed four research directions. Future studies may focus on constructing a "cross life cycle – multi-dimensional" research framework, which will help to more comprehensively grasp the mechanism of action of hormones on woman's cognitive function and neuropsychiatric status at different life stages. The shift in hotspot trend themes from single topics (such as magnetic resonance imaging, hormones and cognition) to diverse health topics (psychiatry and psychology, cancer risk, cardiovascular and cerebrovascular diseases, metabolic diseases, physical activity, etc.) and the shift toward non-hormonal intervention strategies reflect the development trend of the discipline.

    Figures and Tables | References | Related Articles | Metrics
    Animal models of Parkinson’s disease: research status and trend analysis
    Li Huiping, Jia Huanhuan, Zhao Weibo
    2026, 30 (35):  9345-9354.  doi: 10.12307/2026.266
    Abstract ( 35 )   PDF (9139KB) ( 11 )   Save
    BACKGROUND: To further elucidate the etiology and pathogenesis of Parkinson’s disease, standardized animal models that more closely mimic clinical conditions have garnered significant attention and achieved notable progress.
    OBJECTIVE: To review and summarize the current status, development trajectory, and trends in Parkinson’s disease animal model research.
    METHODS: A total of 10 170 relevant literature from two databases, CNKI and Web of Science, were used as data samples. CiteSpace bibliometric software was then used to draw and analyze knowledge graphs of co-occurrence, clustering, emergent terms of keywords, literature publication volume, national/regional publication volume, institutional cooperation network, and literature citation in Parkinson’s disease animal model research, followed by analysis.
    RESULTS AND CONCLUSION: The overall publication volume of Parkinson’s disease animal model research, both domestically and internationally, has shown a fluctuating upward trend, with significant growth observed in the Web of Science database. China and the United States were the top publishing countries, accounting for 52.6% of total publications and emerging as primary contributors to research outcomes in this field. The leading domestic institution was Shanghai University of Traditional Chinese Medicine (131 papers), while internationally, Harvard University was the institution with the most publications (263 papers). Publications are domestic and foreign journals and disciplines including neuroscience, neurology, molecular biology, traditional Chinese medicine, basic medicine, and pharmacology, etc. Especially, traditional Chinese medicine has received high attention from domestic scholars in the treatment of Parkinson’s disease, and its interdisciplinary cooperation potential is enormous. Neuroinflammation, gut microbiota, oxidative stress, mitochondrial dysfunction, alpha synuclein and other pathological mechanisms related to Parkinson’s disease animal models are research hotspots in this field. Ferroptosis has become an emerging theme in the study of Parkinson’s disease mechanisms in China. In the treatment of Parkinson’s disease, in addition to the continuous deepening of Parkinson’s disease treatment research in traditional Chinese medicine and Western medicine through animal models, new methods such as gene therapy and stem cell transplantation have provided innovative treatment strategies in Parkinson’s disease animal model research. With the advancement of the national “China Brain Project” and developments in gene editing, artificial intelligence, machine learning, and brain-computer interface technologies, these emerging techniques also present significant exploration potential in future Parkinson’s disease research.

    Figures and Tables | References | Related Articles | Metrics
    Xiao Ban Tong Mai Fang regulates autophagy via targeting miR-126-3p: bioinformatics analysis for prevention and treatment of atherosclerosis
    Cao Shan, Wang Yanxi, Duan Kaixuan, Qi Xiang, Wang Yuhan
    2026, 30 (35):  9355-9364.  doi: 10.12307/2026.404
    Abstract ( 28 )   PDF (11523KB) ( 17 )   Save
    BACKGROUND: Studies have shown that miR-126-3p plays an important role in regulating autophagy and is closely related to the occurrence and development of atherosclerosis. Xiao Ban Tong Mai Fang can exert anti-atherosclerotic effects by exerting anti-inflammatory effects and inhibiting the proliferation of human aortic vascular smooth muscle cells.
    OBJECTIVE: To explore the mechanism of Xiao Ban Tong Mai Fang in the treatment of atherosclerosis by targeting microRNAs (miRNAs) to regulate autophagy using bioinformatics techniques.
    METHODS: Machine learning methods were used to screen the differentially expressed miRNAs in the atherosclerosis dataset GSE137580. The screened miRNAs were intersected with the key module genes screened by weighted gene co-expression network analysis. The potential regulatory genes of the intersected miRNAs were predicted based on the database, and then the predicted genes were intersected with the autophagy gene set. Protein-protein interaction analysis and enrichment analysis were conducted on the intersected genes, and experimental verification was conducted in combination with the results of the enrichment analysis. Human umbilical vein endothelial cells and RAW264.7 cells were cultured in vitro. An atherosclerosis cell foam model was established by induction with oxidized low-density lipoprotein, and quantitative real-time polymerase chain reaction (qPCR) was used to detect the differential expression of miR-126-3p. An overexpression vector of miR-126-3p was constructed, and qPCR was used to detect the transfection efficiency and the intervention effect of Xiao Ban Tong Mai Fang. Western blot was used to detect the regulatory effect of Xiao Ban Tong Mai Fang on autophagy and the mitogen-activated protein kinase (MAPK) pathway in human umbilical vein endothelial cells.
    RESULTS AND CONCLUSION: (1) A total of 10 key miRNAs were identified by combining machine learning and weighted gene co-expression network analysis. Based on literature review and previous research, miR-126-3p was selected for experimental verification. After intersecting the 3 892 predicted potential regulatory genes with the autophagy gene set, 257 autophagy-related genes were obtained. Enrichment analysis found that these genes were widely enriched in the MAPK signaling pathway, so this pathway was selected for experimental verification. (2) The results of qPCR showed that miR-126-3p was upregulated in human umbilical vein endothelial cells and RAW264.7 cell foam models induced by oxidized low-density lipoprotein (P < 0.05). (3) After intervention with Xiao Ban Tong Mai Fang, the expression of miR-126-3p in human umbilical vein endothelial cells of the mimic group was significantly decreased (P < 0.05). (4) The results of western blot showed that intervention with Xiao Ban Tong Mai Fang inhibited the expression of autophagy-related proteins lipidated/non-lipidated forms of microtubule-associated protein 1 light chain 3 (LC3-II/LC3-I) and autophagy adaptor protein p62 in human umbilical vein endothelial cells (P < 0.05), and downregulated the expression of proteins in the MAPK pathway (P < 0.05). This effect was similar to that of the autophagy inhibitor 3-methyladenine. These findings indicate that miR-126-3p is upregulated in the atherosclerosis model, and it is inferred that its abnormal expression may be involved in the pathogenesis of atherosclerosis. Xiao Ban Tong Mai Fang plays a role in treating atherosclerosis by downregulating miR-126-3p, inhibiting the MAPK pathway, and suppressing the autophagy of human umbilical vein endothelial cells.

    Figures and Tables | References | Related Articles | Metrics
    Epidemiological association between metabolic health obesity phenotype and chronic low back pain: a cross-sectional analysis based on the NHANES database
    Ye Shicheng, Liu Yuxin, Zeng Xuan, Sui Lili, Liu Jiao, Chen Yuting, Qu Chongzheng
    2026, 30 (35):  9365-9374.  doi: 10.12307/2026.268
    Abstract ( 60 )   PDF (1685KB) ( 10 )   Save
    BACKGROUND: Currently, whether and how the metabolically healthy obesity phenotype influences the risk and pathological progression of chronic low back pain compared to metabolically unhealthy obese individuals remain unclear. Research is urgently needed to clarify their association and potential mechanisms.
    OBJECTIVE: To investigate the epidemiological association between the metabolically healthy obesity phenotype and chronic low back pain.
    METHODS: Using data from the US National Health and Nutrition Examination Survey (NHANES) 1999-2004 and 2009-2010 (n=4 956), this retrospective cross-sectional study defined obesity status based on body mass index and waist circumference according to World Health Organization criteria. Metabolic phenotypes were stratified using core metabolic syndrome indicators (such as fasting blood glucose, lipid profile, and blood pressure), establishing classifications for metabolically healthy and unhealthy obesity. The adjusted multivariable logistic regression models and restricted cubic splines were constructed to systematically evaluate the nonlinear dose-response relationship between metabolically healthy obesity phenotypes and chronic low back pain risk. An adjusted multivariable model was established to stratify chronic low back pain risk. Model robustness was validated through subgroup analysis, threshold effect analysis, and multiple sensitivity analysis frameworks.
    RESULTS AND CONCLUSION: (1) Metabolically unhealthy obesity significantly increased the risk of chronic low back pain (body mass index standard: OR (95% CI): 1.44 (1.11, 1.85), P = 0.007 0; waist circumference standard: OR (95% CI): 1.57 (1.25, 1.97), P = 0.000 3), smoking (OR (95% CI): 1.44 (1.24, 1.67), P < 0.000 1), arthritis (OR (95% CI): 2.44 (2.06, 2.88), P < 0.000 1), and other comorbidities significantly amplified the risk effect of metabolically healthy obesity on chronic low back pain. Body mass index ≥ 39.73 kg/m2 and waist circumference ≥ 125 cm served as risk thresholds for chronic low back pain in metabolically unhealthy individuals. Low education level and income, and widowed/divorced or separated status increased the risk of chronic low back pain. A linear relationship existed between body mass index and chronic low back pain in the total population and among metabolically unhealthy participants (P < 0.05). Among metabolically healthy participants, the dose-response relationship between body mass index and chronic low back pain exhibited an approximately linear relationship (P > 0.05). An approximately linear dose-response relationship was observed for chronic low back pain across the total population, metabolically healthy participants, and metabolically unhealthy participants (P > 0.05). (2) Cross-sectional analysis based on NHANES data revealed a significant positive independent association between metabolically unhealthy obesity and chronic low back pain. The association between metabolically healthy obesity and chronic low back pain was weak and not statistically significant, indicating that metabolic health status is an important confounding factor influencing the occurrence of chronic low back pain in obese populations. The association model between metabolically healthy obesity and chronic low back pain established through international research provides a critical theoretical reference for exploring racial heterogeneity and localized mechanisms (e.g., Asia-specific metabolic thresholds) in similar conditions among the Chinese population. The findings suggest that it is urgent to address low back pain risks among metabolically healthy obese populations, promote optimized clinical classification intervention strategies (e.g., avoiding excessive weight loss), and proactively prevent the public health burden of obesity-related musculoskeletal diseases in the Chinese population.

    Figures and Tables | References | Related Articles | Metrics
    Lung tissue repair mechanisms and risk models for chronic obstructive pulmonary disease: an analysis based on computer simulation and experimental validation
    Chen Yanni, Chen Liang, Zhang Jianhong, Lu Zhenfang, Liu Min, Li Jian
    2026, 30 (35):  9375-9380.  doi: 10.12307/2026.444
    Abstract ( 21 )   PDF (1333KB) ( 4 )   Save
    BACKGROUND: Understanding the characteristics of lung tissue repair and risk factors in patients with chronic obstructive pulmonary disease is crucial for improving disease management and enhancing patient quality of life. Existing clinical indicators cannot accurately quantify the tissue repair potential and disease progression risk in patients with a history of frequent hospitalizations.
    OBJECTIVE: To conduct a risk prediction model analysis of lung tissue repair mechanisms in chronic obstructive pulmonary disease based on computer simulation and case validation, thereby promoting lung tissue repair/regeneration in patients with chronic obstructive pulmonary disease, reducing the frequency of hospitalizations, and improving the quality of life.
    METHODS: Medical records from 200 patients with chronic obstructive pulmonary disease hospitalized at Beijing Jingmei Group General Hospital for from 2022-10-01 to 2023-10-01 were collected. Patients were grouped based on the number of hospitalizations for chronic obstructive pulmonary disease within 1 year after discharge: 100 patients hospitalized ≥ 2 times within 1 year were classified as the frequent hospitalization group, while 100 patients hospitalized < 2 times within 1 year were classified as the non-frequent hospitalization group. General clinical data, pulmonary function, blood gas analysis, and hematological indicators were collected and compared between the two groups. Variables with P < 0.05 were progressively incorporated into a multivariate logistic regression model to identify risk factors for re-admission within 1 year after discharge. The area under the receiver operating characteristic curve was used to evaluate the predictive performance of the clinical risk factor model for re-admission within 1 year.
    RESULTS AND CONCLUSION: (1) Pulmonary function: Significant differences were observed between the two groups in the following parameters (P < 0.05): percentage of forced expiratory volume in one second relative to predicted value, forced vital capacity, percentage of forced vital capacity relative to predicted value, ratio of forced expiratory volume in one second to forced vital capacity, residual volume/total lung capacity ratio, pulmonary diffusion capacity for carbon monoxide, and carbon monoxide diffusion capacity per unit alveolar volume. (2) Blood gas analysis: Significant differences were observed between the two groups in terms of partial pressure of oxygen, partial pressure of carbon dioxide, oxygen saturation, and type of respiratory failure (P < 0.05). (3) Hematological indicators: Significant differences were observed between the two groups in terms of absolute neutrophil count, D-dimer levels, absolute lymphocyte count, neutrophil percentage, and red cell distribution width (P < 0.05). However, no significant differences were found between the two groups in terms of eosinophil percentage, fibrinogen levels, and absolute eosinophil count (P > 0.05). (4) Logistic regression analysis revealed that the percentage of forced expiratory volume in the first second relative to the predicted value [odds ratio (OR)=1.01, 95% confidence interval (CI): 1.004-1.017, P=0.011], carbon monoxide diffusion capacity (OR=2.28, 95% CI: 1.270-3.025, P=0.004), type I respiratory failure (OR=3.15, 95% CI: 2.414-5.947, P=0.001), type II respiratory failure (OR=7.03, 95% CI: 1.688-8.604, P=0.001), and red cell distribution width (OR=1.50, 95% CI: 0.65-3.44, P < 0.0001) were risk factors for frequent hospitalizations in patients with chronic obstructive pulmonary disease. (5) Analysis of the area under the receiver operating characteristic curve revealed that when the forced expiratory volume in 1 second was below 52.9% of predicted value, the risk of frequent hospitalizations increased in patients with chronic obstructive pulmonary disease. When the carbon monoxide diffusion capacity was below 4 mmol/(min·kPa), the risk of frequent hospitalizations increased in patients with chronic obstructive pulmonary disease; the risk of frequent hospitalizations increased in chronic obstructive pulmonary disease patients with type I respiratory failure. When the red cell distribution width exceeded 14.5%, the risk of frequent hospitalizations increased in patients with chronic obstructive pulmonary disease. (6) Logistic regression modeling and receiver operating characteristic curve analysis revealed that severe impairment of diffusion capacity, concomitant respiratory failure, and elevated red cell distribution width are major risk factors for frequent hospitalizations in patients with chronic obstructive pulmonary disease. Early identification and timely intervention targeting these factors are crucial for enhancing lung tissue repair potential, predicting disease progression risk, and improving quality of life in such patients.

    Figures and Tables | References | Related Articles | Metrics